Friday, February 7, 2025
spot_img

Fulcrum Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CAMBRIDGE, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 at 1:20 pm ET.

The webcast of the fireside chat will be accessible HERE and by visiting the “Events and Presentations” section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcast will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentation.

About Fulcrum Therapeutics
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum’s lead program in clinical development is pociredir, a small molecule designed to increase expression of fetal hemoglobin and in development for the treatment of sickle cell disease (SCD). Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, visit www.fulcrumtx.com and follow us on Twitter/X (@FulcrumTx) and LinkedIn.

Contact:
Chris Calabrese
LifeSci Advisors, LLC
[email protected]

Kevin Gardner
LifeSci Advisors, LLC
[email protected]

Powered by SlickText.com

Hot this week

Danske Bank A/S initiates share buy-back programme

Company announcement no 6 2025Danske BankBernstorffsgade 40DK-1577 København VTel....

Realkredit Danmark recorded a net profit of DKK 4,424 million for 2024

Press release Tel. +45 45 14 14 007 February 2025...

Iveco Group 2024 Full Year and Fourth Quarter Results

The following is an extract from the “Iveco Group...

Topics

spot_img

Related Articles

Popular Categories

spot_img